Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production

被引:43
作者
Miyachi, H
Azuma, A
Hioki, E
Iwasaki, S
Kobayashi, Y
Hashimoto, Y
机构
[1] UNIV TOKYO,INST MOL & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,JAPAN
[2] TOHO UNIV,FAC SCI,FUNABASHI,CHIBA 274,JAPAN
关键词
D O I
10.1006/bbrc.1996.1043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Regulation by thalidomide [N(alpha)-phthalimidoglutarimide] of tumor necrosis factor (TNF)-alpha production was found to be inducer-specific. Thalidomide enhances TNF-alpha production by human leukemia HL-60 cells induced with 12-O-tetradecanoylphorbol 13-acetate (TPA), while it inhibits TNF-alpha production induced with okadaic acid (OA) in the same cell line. Some phthalimide analogs, including PP-33 [2-(2,6-diisopropylphenyl)-1H-isoindole-1,3-dione] and its 4,5.6,7-tetrafluoro derivative (FPP-33), also showed such an inducer-specific bidirectional TNF-alpha production-regulating activity. The structure-activity relationships of the compounds tested are similar, but not identical, in the TPA-stimulated HL-60 and OA-stimulated HL-60 assay systems. (C) 1996 Academic Press, Inc.
引用
收藏
页码:426 / 430
页数:5
相关论文
共 21 条
[1]  
ATRA E, 1993, CLIN EXP RHEUMATOL, V11, P487
[2]  
FUJIKI H, 1989, ENVIRON CARCINOG REV, V7, P1
[3]   TUMOR PROMOTION BY INHIBITORS OF PROTEIN PHOSPHATASE-1 AND PHOSPHATASE-2A - THE OKADAIC ACID CLASS OF COMPOUNDS [J].
FUJIKI, H ;
SUGANUMA, M .
ADVANCES IN CANCER RESEARCH, VOL 61, 1993, 61 :143-194
[4]   CYTOSOLIC-NUCLEAR TUMOR PROMOTER-SPECIFIC BINDING-PROTEIN - ASSOCIATION WITH THE 90 KDA HEAT-SHOCK PROTEIN AND TRANSLOCATION INTO NUCLEI BY TREATMENT WITH 12-O-TETRADECANOYLPHORBOL 13-ACETATE [J].
HASHIMOTO, Y ;
SHUDO, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (06) :665-675
[5]   CYTOSOLIC-NUCLEAR TUMOR PROMOTER-SPECIFIC BINDING-PROTEIN (CN-TPBP) IN HUMAN PROMYELOCYTIC LEUKEMIA-CELLS HL-60 [J].
HASHIMOTO, Y ;
SHUDO, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 166 (03) :1126-1132
[6]   THALIDOMIDE UPDATE - REGULATORY ASPECTS [J].
KELSEY, FO .
TERATOLOGY, 1988, 38 (03) :221-226
[7]  
KOMORI A, 1993, CANCER RES, V53, P3462
[8]  
KOMORI A, 1993, CANCER RES, V53, P1982
[9]   THALIDOMIDE INHIBITS THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
MAKONKAWKEYOON, S ;
LIMSONPOBRE, RNR ;
MOREIRA, AL ;
SCHAUF, V ;
KAPLAN, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5974-5978
[10]  
MIZOGUCHI H, 1994, BIOL PHARM BULL, V17, P1114